Respiratory Drug Focus of New Clinical Trial for Parkinsonís Disease

Share

(February 25, 2016) – Ambroxol, a medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson’s disease. Read more

Click for a printer friendly version

Back to top